Acid alpha-glucosidase deficiency (Pompe disease)

@article{Fukuda2007AcidAD,
  title={Acid alpha-glucosidase deficiency (Pompe disease)},
  author={T. Fukuda and A. Roberts and P. Plotz and N. Raben},
  journal={Current Neurology and Neuroscience Reports},
  year={2007},
  volume={7},
  pages={71-77}
}
  • T. Fukuda, A. Roberts, +1 author N. Raben
  • Published 2007
  • Biology, Medicine
  • Current Neurology and Neuroscience Reports
  • The development and recent approval of recombinant acid alpha-glucosidase for enzyme replacement therapy have been major milestones in Pompe disease research. Acid alpha-glucosidase is the enzyme responsible for degradation of glycogen polymers to glucose in the acidic milieu of the lysosomes. Cardiac and skeletal muscles are the two major tissues affected by the accumulation of glycogen within the lysosomes. Both cardiomyopathy and skeletal muscle myopathy are observed in patients with… CONTINUE READING
    43 Citations
    Late form of Pompe disease with glycogen storage in peripheral nerves axons
    • 5
    Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches.
    • 34
    • PDF
    Infantile hypotonia with failure to thrive
    • PDF
    Temporal Neuropathologic and Behavioral Phenotype of 6neo/6neo Pompe Disease Mice
    • 66
    • PDF
    Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease.
    • D. Falk, C. Mah, +5 authors B. Byrne
    • Medicine
    • Molecular therapy : the journal of the American Society of Gene Therapy
    • 2013
    • 50
    • PDF

    References

    SHOWING 1-10 OF 59 REFERENCES
    Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    • N. Raben, T. Fukuda, +8 authors P. Plotz
    • Biology, Medicine
    • Molecular therapy : the journal of the American Society of Gene Therapy
    • 2005
    • 116
    Autophagy and Lysosomes in Pompe Disease
    • 100
    Enzyme replacement therapy in the mouse model of Pompe disease.
    • 174
    Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease.
    • T. Fukuda, M. Ahearn, +5 authors N. Raben
    • Biology, Medicine
    • Molecular therapy : the journal of the American Society of Gene Therapy
    • 2006
    • 145
    • PDF